The Swiss pharmaceutical firm says the acquisition would complement its current pipeline of therapies for neuromuscle problems.
Source link
Novartis Agrees to Acquire Avidity Biosciences for $12 Billion
Related Posts
Trump-Xi meeting puts AI safety, chips and U.S.-China rivalry in focus
President Donald Trump needs the U.S. to beat China within the synthetic intelligence race. However as he meets Chinese language…
Nvidia’s Reign Invites Disruption and an Open-Source Future
Nvidia leads AI at this time, however open-source challengers and customized chips are quickly shifting the steadiness of energy in…
Here’s Every Country Directly Impacted by the War on Iran
On February 28, United States and Israeli forces launched a series of strikes on Iran, kicking off turmoil within the…